1. Home
  2. PLSE vs CRAI Comparison

PLSE vs CRAI Comparison

Compare PLSE & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CRAI
  • Stock Information
  • Founded
  • PLSE 2014
  • CRAI 1965
  • Country
  • PLSE United States
  • CRAI United States
  • Employees
  • PLSE N/A
  • CRAI N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CRAI Other Consumer Services
  • Sector
  • PLSE Health Care
  • CRAI Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • CRAI Nasdaq
  • Market Cap
  • PLSE 1.1B
  • CRAI 1.3B
  • IPO Year
  • PLSE 2016
  • CRAI 1998
  • Fundamental
  • Price
  • PLSE $15.30
  • CRAI $179.85
  • Analyst Decision
  • PLSE
  • CRAI Buy
  • Analyst Count
  • PLSE 0
  • CRAI 1
  • Target Price
  • PLSE N/A
  • CRAI $228.00
  • AVG Volume (30 Days)
  • PLSE 182.5K
  • CRAI 123.0K
  • Earning Date
  • PLSE 08-11-2025
  • CRAI 07-31-2025
  • Dividend Yield
  • PLSE N/A
  • CRAI 1.09%
  • EPS Growth
  • PLSE N/A
  • CRAI 21.18
  • EPS
  • PLSE N/A
  • CRAI 7.40
  • Revenue
  • PLSE N/A
  • CRAI $697,476,000.00
  • Revenue This Year
  • PLSE N/A
  • CRAI $7.47
  • Revenue Next Year
  • PLSE N/A
  • CRAI $4.48
  • P/E Ratio
  • PLSE N/A
  • CRAI $24.29
  • Revenue Growth
  • PLSE N/A
  • CRAI 8.49
  • 52 Week Low
  • PLSE $9.70
  • CRAI $133.54
  • 52 Week High
  • PLSE $25.00
  • CRAI $214.01
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 37.88
  • CRAI 42.07
  • Support Level
  • PLSE $15.92
  • CRAI $180.68
  • Resistance Level
  • PLSE $17.81
  • CRAI $185.76
  • Average True Range (ATR)
  • PLSE 0.91
  • CRAI 5.14
  • MACD
  • PLSE -0.23
  • CRAI -1.38
  • Stochastic Oscillator
  • PLSE 21.89
  • CRAI 37.53

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

Share on Social Networks: